levodopa/carbidopa (CP-012)
/ BDD Pharma, Bukwang Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 19, 2023
Quality of life with continuous subcutaneous levodopa/carbidopa infusion: Exploratory findings from the ND0612 BeyoND study
(PSG 2023)
- "This open-label study provides preliminary support for the 12-month efficacy of treatment with ND0612 in improving quality of life and global clinical status in PwP experiencing motor fluctuations."
Clinical
March 28, 2023
Management of Dyskinesia and Advances in Treatment of Parkinson’s Disease : Episode 1: Treatment Options for Parkinson Disease
(NeurologyLive)
- "Dr William G. Ondo provides an overview of available treatments and pharmacokinetic properties of different drugs for Parkinson Disease....Daniel E. Kremens, MD, JD: Hello and welcome to this NeurologyLive Peer Exchange titled, 'Management of Dyskinesia and Advances in Treatment of Parkinson Disease.' I’m your host, Dr Daniel Kremens...And Dr Fernando Pagan...."
Video
1 to 2
Of
2
Go to page
1